^○Jung Goo LEE^{1, 2, 3}, Ah Jeong CHOI¹, Mi Kyoung SEO¹, Sung Woo PARK^{1, 3, 4} (1. Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea., 2. Department of Psychiatry, College of Medicine, Haeundae Paik Hospital, Inje University, Busan, Republic of Korea., 3. Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Republic of Korea.)

^○Jung Goo LEE^{1, 2, 3}, Ah Jeong CHOI¹, Mi Kyoung SEO¹, Sung Woo PARK^{1, 3, 4} (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea. , 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

^○Jung Goo LEE^{1, 2, 3}, Ah Jeong CHOI¹, Mi Kyoung SEO¹, Sung Woo PARK^{1, 3, 4} (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea. , 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

^○Jung Goo LEE^{1, 2, 3}, Ah Jeong CHOI¹, Mi Kyoung SEO¹, Sung Woo PARK^{1, 3, 4} (1. Paik Institute for Clinical Research, Inje University, Busan, Korea., 2. Department of Psychiatry, Inje University Haeundae Paik Hospital, Busan, Korea, 3. Department of Health Science and Technology, Graduate School, Inje University, Korea., 4. Department of Convergence Biomedical Science, College of Medicine, Inje University, Busan, Korea.)

^○Yu-Cheng HO (Department of Medicine, Mackay Medical College, New Taipei, Taiwan)

^○Yuko NAKATAKE^{1, 2}, Misa YAMADA², Hiroki FURUIE², Kazumi YOSHIZAWA¹, Mitsuhiko YAMADA² (1. Laboratory of Pharmacology and Therapeutics, Graduate school of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan, 2. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○HIROSHI KUNIISHI¹, Daisuke YAMADA², Keiji WADA², Mitsuhiko YAMADA¹, Masayuki SEKIGUCHI² (1. Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 2. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan)